ask="18.50"
ask_size="1000"
average_daily_volume="536849"
bid="10.00"
bid_size="100"
book_value="8.67"
change="+0.21"
change_from_200_day_moving_average="-4.91"
change_from_50_day_moving_average="0.79"
change_from_52_week_high="-30.69"
change_From_52_week_low="4.09"
change_in_percent="+1.47%"
close="14.51"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.69"
ebitda="-118.06M"
eps_estimate_current_year="-3.28"
eps_estimate_next_quarter="-0.78"
eps_estimate_next_year="-3.61"
ex_dividend_date="N/A"
float_shares="34538000"
high="14.60"
high_52_weeks="45.20"
last_trade_date="3/10/2017"
last_trade_price="14.51"
last_trade_size="16133"
last_trade_time="4:00pm"
low="14.02"
low_52_weeks="10.43"
market_capitalization="629.88M"
moving_average_200_day="19.42"
moving_average_50_day="13.72"
name="Intra-Cellular Therapies Inc."
notes="N/A"
one_year_target_price="35.63"
open="14.46"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-25.28%"
percent_change_from_50_day_moving_average="+5.79%"
percent_change_from_52_week_high="-67.90%"
percent_change_from_52_week_low="+39.18%"
previous_close="14.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.65"
price_per_sales="1877.11"
revenue="330702.00"
shares_outstanding="43410000"
short_ratio="13.75"
stock_exchange="NMS"
symbol="ITCI"
volume="283997"
weeks_range_52="10.43 - 45.20"
